4-[5-(tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl]morpholine

Product Information

Molecular Formula:
C15H23BN2O3
Molecular Weight:
290.166
Description
4-[5-(tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl]morpholine plays a crucial role in the development of potential drugs for treating specific diseases. Its unique chemical structure enables targeted interactions with specific receptors or enzymes involved in diseases like cancer, inflammation, or neurological disorders.
Synonyms
1-[5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl]morpholine
IUPAC Name
4-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl]morpholine
Canonical SMILES
B1(OC(C(O1)(C)C)(C)C)C2=CN=C(C=C2)N3CCOCC3
InChI
InChI=1S/C15H23BN2O3/c1-14(2)15(3,4)21-16(20-14)12-5-6-13(17-11-12)18-7-9-19-10-8-18/h5-6,11H,7-10H2,1-4H3
InChI Key
ZGDLVKWIZHHWIR-UHFFFAOYSA-N
Melting Point
135-139 °C (lit.)
Flash Point
Not applicable
Purity
97%

Computed Properties

Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
5
Rotatable Bond Count
2
Exact Mass
290.1801728 g/mol
Monoisotopic Mass
290.1801728 g/mol
Topological Polar Surface Area
43.8Ų
Heavy Atom Count
21
Formal Charge
0
Complexity
356
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
0
Defined Bond Stereocenter Count
0
Undefined Bond Stereocenter Count
0
Covalently-Bonded Unit Count
1
Compound Is Canonicalized
Yes

Patents

Publication Number Title Priority Date
WO-2021194326-A1 Aminopyrimidine derivatives and their use as aryl hydrocarbon receptor modulators 2020-03-27
US-2021106588-A1 Bicyclic heterocycles as fgfr inhibitors 2019-10-14
WO-2021076602-A1 Bicyclic heterocycles as fgfr inhibitors 2019-10-14
TW-202128685-A Bicyclic heterocycles as fgfr inhibitors 2019-10-14
WO-2021023813-A1 5-heteroaryl-pyridin-2-amine confounds as neuropeptide ff receptor antagonists 2019-08-06
WO-2020247804-A1 Heterocycle substituted pyridine derivative antifungal agents 2019-06-07
WO-2020121261-A1 3,3-difluoroallylamines or salts thereof and pharmaceutical compositions comprising the same 2018-12-14
WO-2020121263-A1 Triazolopyridin-3-ones or their salts and pharmaceutical compositions comprising the same 2018-12-14
US-2020223827-A1 3,3-difluoroallylamines or salts thereof and pharmaceutical compositions comprising the same 2018-12-14
US-2020223844-A1 Triazolopyridin-3-ones or their salts and pharmaceutical compositions comprising the same 2018-12-14
The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Online Inquiry
  • Verification code
USA
  • International:
  • US & Canada (Toll free):
  • Email:
  • Fax:
UK
  • Email:
Copyright © 2025 BOC Sciences. All rights reserved.
Top
Inquiry Basket